论文部分内容阅读
近10余年,经静脉输入溶栓剂链激酶以溶化动脉栓子,有许多报道.新近选择动脉内小剂量链激酶注射,使药物直接对血栓起作用,目前认为这是用溶栓剂治疗动脉栓塞的首选输注途径.作者报告8例腘胫动脉栓塞的病人,用小剂量链激酶经动脉导管输至动脉血栓部位,治疗成功.作者报道8例单侧或双侧腘或胫动脉急性血栓栓塞的病人,经股动脉置入的动脉导管注入链激酶,使其直接送到血栓部位.7例男性,1例女性,平均年龄64岁.2例患糖尿病,3例患有未确诊的膕动脉瘤,
Nearly 10 years, the intravenous infusion of thrombolytic streptokinase to dissolve arterial emboli, there are many reports.Nearly selected small doses of intra-arterial injections of streptokinase, the drug directly on the role of thrombosis, which is currently considered thrombolytic therapy of arteries Embolism of the preferred route of infusion.The authors report 8 cases of tibial artery embolization patients with small doses of streptokinase via the arterial catheter to the arterial thrombosis site, the successful treatment of the authors reported 8 cases of unilateral or bilateral or tibia artery acute thrombosis In patients with embolism, streptokinase was infused through the catheter placed in the femoral artery and delivered directly to the thrombus site.7 males and 1 females, with an average age of 64 years2 with diabetes and 3 with undiagnosed Aneurysm,